Related Experiment Video
Updated: Jul 7, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
[Our experiences with therapeutic hypothermia]
Milovan Petrović1, Ilija Srdanović, Gordana Panić
1Institut za kardiovaskularne bolesti, 21204 Sremska Kamenica, Klinka za kardiologiju. nsbim@EUnet.yu
Insights
Therapeutic hypothermia, a method to lower body temperature, significantly improves neurological recovery and survival rates in comatose patients following cardiac arrest. This neuroprotective strategy enhances outcomes for cardiac arrest survivors.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Context:
- Cardiac arrest is a leading cause of global cerebral ischemia, with high mortality and poor neurological outcomes.
- A significant percentage of cardiac arrest survivors remain comatose, necessitating effective neuroprotective strategies.
- Mild hypothermia has demonstrated neuroprotective effects in resuscitation, improving survival in anoxic conditions.
Purpose:
- To evaluate the efficacy of therapeutic hypothermia in improving neurological outcomes and reducing mortality in comatose patients after cardiac arrest.
- To assess the neurological recovery and survival rates in patients treated with mild hypothermia following resuscitation.
Summary:
- Twelve comatose patients were treated with therapeutic hypothermia (target 33°C for 24 hours) using combined intravascular and external cooling methods.
- 50% of patients achieved complete neurological recovery, and 16.6% had partial recovery.
- Overall survival was 41.66%, with a primary cause of cardiac arrest being acute myocardial infarction.
Impact:
- Mild resuscitative hypothermia improves neurological outcomes in comatose survivors of cardiac arrest.
- This neuroprotective approach reduces mortality rates, offering a significant benefit to patients.
- The findings support the clinical application of therapeutic hypothermia as a standard of care post-cardiac arrest.
Introduction:
The single most important clinically relevant cause of global cerebral ischemia is cardiac arrest. The estimated rate of sudden cardiac arrest is between 40 and 130 cases per 100.000 people per year. Almost 80% of patients initially resuscitated from cardiac arrest remain comatose for more than one hour. One year after cardiac arrest only 10-30% of these patients survive with good neurological outcome. The ability to survive anoxic no-flow states is dramatically increased with protective and preservative hypothermia. The results of clinical studies show a marked neuroprotective effect of mild hypothermia in resuscitation.
Material And Methods:
In our clinic, 12 patients were treated with therapeutic hypothermia. A combination of intravascular and external method of cooling was used according to the ILCOR (International Liaison Committee on Resuscitation) guidelines. The target temperature was 33 degrees C, while the duration of cooling was 24 hours. After that, passive rewarming was allowed. All patients also received other necessary therapy.
Results:
Six patients (50%) had a complete neurological recovery. Two patients (16.6%) had partial neurological recovery. Four patients (33.3%) remained comatose. Five patients (41.66%) survived, while 7 (58.33%) patients died. The main cause of cardiac arrest was acute myocardial infarction (91.6%). One patient had acute myocarditis.
Conclusion:
Mild resuscitative hypothermia after cardiac arrest improves neurological outcome and reduces mortality in comatose survivors.
More Related Videos
Related Concept Videos
Decreased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Homeostatic Imbalances in Body Temperature
Increased Body Temperature
Factors Affecting Body Temperature
Factors may include:
Thermosensation

